Systemic concentrations of short chain fatty acids are elevated in salmonellosis and exacerbation of familial mediterranean fever

Frontiers in Microbiology

Volumn 7, Issue MAY, 2016, Pages

  Ktsoyan, Zhanna A ^a   Mkrtchyan, Mkhitar S ^a   Zakharyan, Magdalina K ^a   Mnatsakanyan, Armine A ^b   Arakelova, Karine A ^a   Gevorgyan, Zaruhi U ^b   Sedrakyan, Anahit M ^a   Hovhannisyan, Alvard I ^a   Arakelyan, Arsen A ^a   Aminov, Rustam I ^c  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^b Armenian Ministry of Health   (Armenia)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Familial Mediterranean fever; Inflammation; Peripheral blood; Salmonella; Salmonellosis; Short chain fatty acids

Indexed keywords

GALACTITOL; SHORT CHAIN FATTY ACID;

ABDOMINAL CRAMP; ANAMNESIS; ARTICLE; AUTOINFLAMMATORY DISEASE; CONTROLLED STUDY; DIARRHEA; FAMILIAL MEDITERRANEAN FEVER; FEVER; GAS CHROMATOGRAPHY; GASTROENTERITIS; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; NAUSEA; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SALMONELLOSIS; VOMITING;

EID: 84973442837     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00776     Document Type: Article

References (57)

1. Ahmer, B. M., and Gunn, J. S. (2011). Interaction of Salmonella spp. with the intestinal microbiota. Front. Microbiol. 6:101. doi: 10.3389/fmicb.2011.00101
2. Barman, M., Unold, D., Shifley, K., Amir, E., Hung, K., Bos, N., et al. (2008). Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76, 907-915. doi: 10.1128/IAI.01432-07
3. Bienenstock, J., Kunze, W., and Forsythe, P. (2015). Microbiota and the gut-brain axis. Nutr. Rev. 73, 28-31. doi: 10.1093/nutrit/nuv019
4. Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J. D., Serino, M., et al. (2014). Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol. 14:189. doi: 10.1186/s12876-014-0189-7
5. Bloemen, J. G., Olde Damink, S. W. M., Venema, K., Buurman, W. A., Jalan, R., and Dejong, C. H. C. (2010). Short chain fatty acids exchange: is the cirrhotic, dysfunctional liver still able to clear them? Clin. Nutr. 29, 365-369. doi: 10.1016/j.clnu.2009.10.002
6. Bloemen, J. G., Venema, K., van de Poll, M. C., Olde Damink, S. W., Buurman, W. A., and Dejong, C. H. (2009). Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin. Nutr. 28, 657-661. doi: 10.1016/j.clnu.2009.05.011
7. Brydges, S., and Kastner, D. L. (2006). The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr. Top. Microbiol. Immunol. 305, 127-160. doi: 10.1007/3-540-29714-6_7
8. Byrne, C. S., Chambers, E. S., Morrison, D. J., and Frost, G. (2015). The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. (Lond). 39, 1331-1338. doi: 10.1038/ijo.2015.84
9. Cerf-Bensussan, N., and Gaboriau-Routhiau, V. (2010). The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol. 10, 735-744. doi: 10.1038/nri2850
10. Cook, S. I., and Sellin, J. H. (1998). Review article: short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 12, 499-507. doi: 10.1046/j.1365-2036.1998.00337.x
11. Cummings, J., Pomare, E., Branch, W., Naylor, C., and Macfarlane, G. (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-1227. doi: 10.1136/gut.28.10.1221
12. Dankert, J., Zijlstra, J. B., and Wolthers, B. G. (1981). Volatile fatty acids in human peripheral and portal blood: quantitative determination vacuum distillation and gas chromatography. Clin. Chim. Acta 110, 301-307. doi: 10.1016/0009-8981(81)90359-4
13. den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D. J., and Bakker, B. M. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325-2340. doi: 10.1194/jlr. R036012
14. Drumo, R., Pesciaroli, M., Ruggeri, J., Tarantino, M., Chirullo, B., Pistoia, C., et al. (2016). Salmonella enterica serovar Typhimurium exploits inflammation to modify swine intestinal microbiota. Front. Cell Infect. Microbiol. 5:106. doi: 10.3389/fcimb.2015.00106
15. González-Quintela, A., Campos, J., Alende, R., López-Soto, A., Tomé, S., Otero, E., et al. (2004). Abnormalities in liver enzyme levels during Salmonella Enteritidis enterocolitis. Rev. Esp. Enferm. Dig. 96, 559-562. doi: 10.4321/S1130-01082004000800005
16. Hawrelak, J. A., and Myers, S. P. (2004). The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 9, 180-197
17. Headland, S. E., and Norling, L. V. (2015). The resolution of inflammation: principles and challenges. Semin. Immunol. 27, 149-160. doi: 10.1016/j.smim.2015.03.014
18. Honda, K., and Littman, D. R. (2012). The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30, 759-795. doi: 10.1146/annurev-immunol-020711-074937
19. Islam, R., Anzai, N., Ahmed, N., Ellapan, B., Jin, C. J., Srivastava, S., et al. (2008). Mouse organic anion transporter 2 (mOat2) mediates the transport of short chain fatty acid propionate. J. Pharmacol. Sci. 106, 525-528. doi: 10.1254/jphs. SC0070291
20. Khachatryan, Z. A., Ktsoyan, Z. A., Manukyan, G. P., Kelly, D., Ghazaryan, K. A., and Aminov, R. I. (2008). Predominant role of host genetics in controlling the composition of gut microbiota. PLoS ONE 3:e3064. doi: 10.1371/journal.pone.0003064
21. Kim, C. H., Park, J., and Kim, M. (2014). Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immun. Netw. 14, 277-288. doi: 10.4110/in.2014.14.6.277
22. Knowles, S. E., Jarrett, I. G., Filsell, O. H., and Ballard, F. J. (1974). Production and utilization of acetate in mammals. Biochem. J. 142, 401-411. doi: 10.1042/bj1420401
23. Ktsoyan, Z. A., Beloborodova, N. V., Sedrakyan, A. M., Khachatryan, Z. A., Arakelyan, A. A., Aminov, R. I., et al. (2013a). Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome. Front. Cell Infect. Microbiol. 3:2. doi: 10.3389/fcimb.2013.00002
24. Ktsoyan, Z. A., Beloborodova, N. V., Sedrakyan, A. M., Osipov, G. A., Khachatryan, Z. A., Aminov, R. I., et al. (2011). Profiles of microbial fatty acids in the human metabolome are disease-specific. Front. Microbiol. 1:148. doi: 10.3389/fmicb.2010.00148
25. Ktsoyan, Z. A., Ghazaryan, K., Manukyan, G., Martirosyan, A., Mnatsakanyan, À, Arakelova, K., et al. (2013b). Inflammatory responses to Salmonella infections are serotype-specific. Intern. J. Bacteriol. 2013, 7. doi: 10.1155/2013/168179
26. Ktsoyan, Z. A., Mkrtchyan, M. S., Zakharyan, M. K., Mnatsakanyan, A. A., Arakelova, K. A., Aminov, R. I., et al. (2015). Differential induction of total IgE by two Salmonella enterica serotypes. Front. Cell. Infect. Microbiol. 5:43. doi: 10.3389/fcimb.2015.00043
27. Licciardi, P. V., Wong, S.-S., Tang, M. L. K., and Karagiannis, T. C. (2010). Epigenome targeting by probiotic metabolites. Gut Pathog. 2, 24. doi: 10.1186/1757-4749-2-24
28. Livneh, A., and Langevitz, P. (2000). Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract. Res. Clin. Rheumatol. 14, 477-498. doi: 10.1053/berh.2000.0089
29. Livneh, A., Langevitz, P., Zemer, D., Zaks, N., Kees, S., Lidar, T., et al. (1997). Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40, 1879-1885. doi: 10.1002/art.1780401023
30. Manukyan, G., and Aminov, R. (2016). Update on pyrin functions and mechanisms of familial Mediterranean fever. Front. Microbiol. 7:456. doi: 10.3389/fmicb.2016.00456
31. Manukyan, G. P., Ghazaryan, K. A., Ktsoyan, Z. A., Tatyan, M. V., Khachatryan, Z. A., Hakobyan, G. S., et al. (2008a). Cytokine profile of Armenian patients with familial Mediterranean fever. Clin. Biochem. 41, 920-922. doi: 10.1016/j.clinbiochem.2008.03.017
32. Manukyan, G. P., Ghazaryan, K. A., Ktsoyan, Z. A., Khachatryan, Z. A., Arakelova, K. A., Kelly, D., et al. (2008b). Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition. PLoS ONE 3:e3172. doi: 10.1371/journal.pone.0003172
33. Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., et al. (2012). Host-gut microbiota metabolic interactions. Science 336, 1262. doi: 10.1126/science.1223813
34. Parekh, P. J., Balart, L. A., and Johnson, D. A. (2015). The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease. Clin. Transl. Gastroenterol. 6, e91. doi: 10.1038/ctg.2015.16
35. Penders, J., Stobberingh, E. E., van den Brandt, P. A., and Thijs, C. (2007). The role of the intestinal microbiota in the development of atopic disorders. Allergy 62, 1223-1236. doi: 10.1111/j.1398-9995.2007.01462.x
36. Peters, S. G., Pomare, E. W., and Fisher, C. A. (1992). Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 33, 1249-1252. doi: 10.1136/gut.33.9.1249
37. Petersen, C., and Round, J. L. (2014). Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 16, 1024-1033. doi: 10.1111/cmi.12308
38. Pimentel, M., Gunsalus, R. P., Rao, S. S. C., and Zhang, H. (2012). Methanogens in human health and disease. Am. J. Gastroenterol. 1, 28-33. doi: 10.1038/ajgsup
39. Prakash, S., Rodes, L., Coussa-Charley, M., and Tomaro-Duchesneau, C. (2011). Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5, 71-86. doi: 10.2147/BTT.S19099
40. Roy, C. C., Kien, C. L., Bouthillier, L., and Levy, E. (2006). Short-chain fatty acids: ready for prime time? Nutr. Clin. Pract. 21, 351-366. doi: 10.1177/0115426506021004351
41. Scheppach, W., Pomare, E. W., Elia, M., and Cummings, J. H. (1991). The contribution of the large intestine to blood acetate in man. Clin. Sci. (Lond.) 80, 177-182. doi: 10.1042/cs0800177
42. Schuijt, T. J., van der Poll, T., and Wiersinga, W. J. (2012). "Gut microbiome and host defense interactions during critical illness, "in Annual Update in Intensive Care and Emergency Medicine, ed. J.-L. Vincent (Berlin: Springer)
43. Sekirov, I., Gill, N., Jogova, M., Tam, N., Robertson, M., de Llanos, R., et al. (2010). Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota. Gut Microbes 1, 30-41. doi: 10.4161/gmic.1.1.10950
44. Shin, H. J., Anzai, N., Enomoto, A., He, X., Kim, D. K., Endou, H., et al. (2007). Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 45, 1046-1055. doi: 10.1002/hep.21596
45. Skutches, C. L., Holroyde, C. P., Myers, R. N., Paul, P., and Reichard, G. A. (1979). Plasma acetate turnover and oxidation. J. Clin. Invest. 64, 708-713. doi: 10.1172/JCI109513
46. Song, W. S., Nielson, B. R., Banks, K. P., and Bradley, Y. C. (2009). Normal organ standard uptake values in carbon-11 acetate PET imaging. Nucl. Med. Commun. 30, 462-465. doi: 10.1097/MNM.0b013e32832aa7ce
47. Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., et al. (2015). A gut-vascular barrier controls the systemic dissemination of bacteria. Science 350, 830-834. doi: 10.1126/science.aad0135
48. Stecher, B., Chaffron, S., Käppeli, R., Hapfelmeier, S., Freedrich, S., Weber, T. C., et al. (2010). Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 6:e1000711. doi: 10.1371/journal.ppat.1000711
49. Sunkara, L. T., Achanta, M., Schreiber, N. B., Bommineni, Y. R., Dai, G., Jiang, W., et al. (2011). Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression. PLoS ONE 6:e27225. doi: 10.1371/journal.pone.0027225
50. Sunkara, L. T., Jiang, W., and Zhang, G. (2012). Modulation of antimicrobial host defense peptide gene expression by free fatty acids. PLoS ONE 7:e49558. doi: 10.1371/journal.pone.0049558
51. The French Fmf Consortium (1997). A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25-31. doi: 10.1038/ng0997-25
52. The International Fmf Consortium (1997). Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797-807. doi: 10.1016/S0092-8674(00)80539-5
53. van der Beek, C. M., Bloemen, J. G., van den Broek, M. A., Lenaerts, K., Venema, K., Buurman, W. A., et al. (2015). Hepatic uptake of rectally administered butyrate prevents an increase in systemic butyrate concentrations in humans. J. Nutr. 145, 2019-2024. doi: 10.3945/jn.115.211193
54. Velázquez, O. C., Lederer, H. M., and Rombeau, J. L. (1997). Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. Adv. Exp. Med. Biol. 427, 123-134
55. Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., and Curi, R. (2011). Regulation of Inflammation by short chain fatty acids. Nutrients 3, 858-876. doi: 10.3390/nu3100858
56. Winter, S. E., Thiennimitr, P., Winter, M. G., Butler, B. P., Huseby, D. L., Crawford, R. W., et al. (2010). Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426-429. doi: 10.1038/nature09415
57. Wong, J. M., de Souza, R., Kendall, C. W., Emam, A., and Jenkins, D. J. (2006). Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-243. doi: 10.1097/00004836-200603000-00015